FDA Approves Generic Hormone Therapy Patch
The FDA approved the country's first generic version of Climara Pro, a once-weekly transdermal hormone therapy patch for women with intact uteruses. This includes a fixed combination of estradiol and levonorgestrel in specified doses.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed